247 related articles for article (PubMed ID: 17921092)
1. PET/CT and cross sectional imaging of gynecologic malignancy.
Iyer RB; Balachandran A; Devine CE
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S130-8. PubMed ID: 17921092
[TBL] [Abstract][Full Text] [Related]
2. PET/MRI in Gynecologic Malignancy.
Larson M; Lovrec P; Sadowski EA; Pirasteh A
Radiol Clin North Am; 2023 Jul; 61(4):713-723. PubMed ID: 37169433
[TBL] [Abstract][Full Text] [Related]
3. PET/CT in gynecologic malignancies.
Brunetti J
Radiol Clin North Am; 2013 Sep; 51(5):895-911. PubMed ID: 24010912
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Medicine and Molecular Imaging Applications in Gynecologic Malignancies: A Comprehensive Review.
Khessib T; Jha P; Davidzon GA; Iagaru A; Shah J
Semin Nucl Med; 2024 Mar; 54(2):270-292. PubMed ID: 38342655
[TBL] [Abstract][Full Text] [Related]
5. PET/MR imaging in gynecologic cancer: tips for differentiating normal gynecologic anatomy and benign pathology versus cancer.
Sadowski EA; Pirasteh A; McMillan AB; Fowler KJ; Kusmirek JE
Abdom Radiol (NY); 2022 Sep; 47(9):3189-3204. PubMed ID: 34687323
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography-computed tomography imaging for malignancies in women.
Viswanathan C; Bhosale PR; Shah SN; Vikram R
Radiol Clin North Am; 2013 Nov; 51(6):1111-25. PubMed ID: 24210447
[TBL] [Abstract][Full Text] [Related]
7. Role of PET/CT in gynecological tumors based on the revised FIGO staging classification.
Tsujikawa T; Tsuchida T; Yoshida Y; Kurokawa T; Kiyono Y; Okazawa H; Kimura H
Clin Nucl Med; 2011 Sep; 36(9):e114-8. PubMed ID: 21825837
[TBL] [Abstract][Full Text] [Related]
8. The Role of Computed Tomography and Magnetic Resonance Imaging in Gynecologic Oncology.
Laifer-Narin SL; Genestine WF; Okechukwu NC; Hecht EM; Newhouse JH
PET Clin; 2018 Apr; 13(2):127-141. PubMed ID: 29482746
[TBL] [Abstract][Full Text] [Related]
9. What's New in Imaging for Gynecologic Cancer?
Khan SR; Arshad M; Wallitt K; Stewart V; Bharwani N; Barwick TD
Curr Oncol Rep; 2017 Nov; 19(12):85. PubMed ID: 29105030
[TBL] [Abstract][Full Text] [Related]
10. Role of imaging in the pretreatment evaluation of common gynecological cancers.
Miccò M; Sala E; Lakhman Y; Hricak H; Vargas HA
Womens Health (Lond); 2014 May; 10(3):299-321. PubMed ID: 24956296
[TBL] [Abstract][Full Text] [Related]
11. FDG PET-CT of gynecologic cancers: pearls and pitfalls.
Prabhakar HB; Kraeft JJ; Schorge JO; Scott JA; Lee SI
Abdom Imaging; 2015 Oct; 40(7):2472-85. PubMed ID: 25680500
[TBL] [Abstract][Full Text] [Related]
12. Added Value of FDG PET/MRI in Gynecologic Oncology: A Pictorial Review.
Tarcha Z; Konstantinoff KS; Ince S; Fraum TJ; Sadowski EA; Bhosale PR; Derenoncourt PR; Zulfiqar M; Shetty AS; Ponisio MR; Mhlanga JC; Itani M
Radiographics; 2023 Aug; 43(8):e230006. PubMed ID: 37410624
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET Assessment of Other Gynecologic Cancers.
Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
[TBL] [Abstract][Full Text] [Related]
14. Novel imaging modalities in gynecologic cancer.
Brooks RA; Powell MA
Curr Oncol Rep; 2009 Nov; 11(6):466-72. PubMed ID: 19840524
[TBL] [Abstract][Full Text] [Related]
15. PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison.
Queiroz MA; Kubik-Huch RA; Hauser N; Freiwald-Chilla B; von Schulthess G; Froehlich JM; Veit-Haibach P
Eur Radiol; 2015 Aug; 25(8):2222-30. PubMed ID: 26017734
[TBL] [Abstract][Full Text] [Related]
16. Gynecological cancers.
Avril N; Gourtsoyianni S; Reznek R
Methods Mol Biol; 2011; 727():171-89. PubMed ID: 21331934
[TBL] [Abstract][Full Text] [Related]
17. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography.
Williams AD; Cousins C; Soutter WP; Mubashar M; Peters AM; Dina R; Fuchsel F; McIndoe GA; deSouza NM
AJR Am J Roentgenol; 2001 Aug; 177(2):343-8. PubMed ID: 11461859
[TBL] [Abstract][Full Text] [Related]
18. PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.
Dalla Palma M; Gregianin M; Fiduccia P; Evangelista L; Cervino AR; Saladini G; Borgato L; Nicoletto MO; Zagonel V
Crit Rev Oncol Hematol; 2012 Jul; 83(1):84-98. PubMed ID: 22245509
[TBL] [Abstract][Full Text] [Related]
19. Complementary Prognostic Value of Pelvic Magnetic Resonance Imaging and Whole-Body Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Pretreatment Assessment of Patients With Cervical Cancer.
Sala E; Micco M; Burger IA; Yakar D; Kollmeier MA; Goldman DA; Gonen M; Park KJ; Abu-Rustum NR; Hricak H; Vargas HA
Int J Gynecol Cancer; 2015 Oct; 25(8):1461-7. PubMed ID: 26397068
[TBL] [Abstract][Full Text] [Related]
20. PET Imaging for Gynecologic Malignancies.
Friedman SN; Itani M; Dehdashti F
Radiol Clin North Am; 2021 Sep; 59(5):813-833. PubMed ID: 34392921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
